Lymphoma | Norton Healthcare

Indication: Lymphoma

Long-term Follow-up Protocol for Subjects Treated with Adicet Allogeneic Gamma Delta (γδ) CAR T Cell Investigational Products

Sub-indication: Hematological Malignancies

Study Type: Drug Study

Principal Investigator: Don Stevens, M.D.
Norton Cancer Institute

Sponsor: Sponsor: Adicet Therapeutics Inc

Learn more at ClinicalTrials.gov

Email for more information: Heme-NCIReseach@nortonhealthcare.org

Search our entire site.

Schedule an Appointment

Select an appointment date and time from available spots listed below.